Canada markets closed

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3650+0.0950 (+4.19%)
At close: 04:00PM EDT
2.4292 +0.06 (+2.71%)
After hours: 07:37PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

    HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that George Ng, Chief Executive Officer, will present a corporate update at the MedInvest Biotech and Pharma Investor Conference. David Young, Processa’s President of Research & Developm

  • GlobeNewswire

    Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

    HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that the Company will have two posters at the American Association for Cancer Research Annual Meeting 2024 in San Diego from April 5-10, 2024. David Young, PharmD, Ph.D., President of Re

  • GlobeNewswire

    Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

    HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announces that Chief Executive Officer George Ng will present a corporate update at the 2024 BIO CEO & Investor Conference being held on February 26 – 27, 2024 at the Marriott Marquis in New York C